ArticleFrontiers in nutrition2025
The severity of depressive symptoms as a mediator in the sleep-osteoarthritis risk pathway: insights from the ELSA cohort.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Multi-Trajectories of Sleep Disturbance and Depressive Symptoms and Incident Osteoarthritis: Evidence From the English Longitudinal Study of Ageing.Brain and behavior · 2026Article
- [Study on the effect of superficial layer damage on cartilage retention performance].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026Article
- Sleep quality, duration, and multi-trajectories as predictors of rheumatoid arthritis: evidence from the english longitudinal study of ageing.Arthritis research & therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoarthritis (OA) is a major cause of disability in middle-aged and older adults, yet its risk factors and mechanisms require further investigation. The connection between sleep disturbances and OA risk remains controversial, with underlying mechanisms unclear. The research aimed to examine the prospective association between sleep quality, sleep duration, and incident OA, and to evaluate whether the severity of depressive symptoms partially mediate this association. Methods: This analysis included 4,147 ELSA participants aged ≥50 years without baseline OA. Sleep quality (good/intermediate/poor) and duration (short: <7 h, optimal: 7-8 h, long: >8 h) were assessed via questionnaires. The severity of depressive symptoms was measured using the CES-D scale. Incident OA was determined by self-reported physician diagnosis. Multivariable Cox regression modeled associations between sleep (quality/duration) and OA risk. Threshold analysis and restricted cubic splines (RCS) explored the dose-response relationship for sleep duration. Mediation analysis quantified the severity of depressive symptoms' role in the sleep-OA connection. Results: During 102 months of follow-up, 1,333 new OA cases were reported. Cox regression showed that intermediate and poor sleep quality significantly increased OA risk (HR = 1.23 and 1.74, respectively). RCS analysis revealed a U-shaped curve, with the lowest OA risk at 8 h of sleep. Short sleep (<7 h) was associated with higher OA risk (HR = 1.21), while long sleep (>8 h) showed no significant association. The severity of depressive symptoms mediated the relationship between both sleep quality and sleep duration with OA risk (mediation proportions: 22.39 and 22.11%, respectively). Sensitivity analyses confirmed result robustness. Conclusion: Poor sleep quality and short sleep duration are independent risk factors for incident OA in middle-aged and older adults. The severity of depressive symptoms partially mediates this relationship. Maintaining optimal sleep duration (8 h), improving sleep quality, and addressing depressive symptoms may help reduce OA risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.